1-14 of 14
Pieternella Lugtenburg
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved Risk Prediction in DLBCL By Combining Clinical and PET Features with Interim PET Assessment

Christine Hanoun, Martijn Heymans, Sanne Wiegers, Annelies Bes, Ulrich Duehrsen, Andreas Huettmann, Lars Kurch, Sally F Barrington, George Mikhaeel, Pieternella Lugtenburg, Luca Ceriani, Emanuele Zucca, Tamas Gyorke, Sandor Czibor, Gerben Zwezerijnen, Ronald Boellaard, Josée M. Zijlstra, Corinne Eertink
Journal: Blood
Blood (2023) 142 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2023-190277
Published: 2023
Journal Articles

Mitigating the Risk of Cytokine Release Syndrome (CRS): Preliminary Results from a DLBCL Cohort of Epcore NHL-1

Julie M. Vose, Tatyana Feldman, Martine E.D. Chamuleau, Won Seog Kim, Pieternella Lugtenburg, Tae Min Kim, Pau Abrisqueta Costa, Chan Y. Cheah, Ingrid Cecilia Glimelius, Brian Hess, Wojciech Jurczak, Gerardo Musuraca, Adam J. Olszewski, Minh Dinh, Nurgul Kilavuz, Monica Wielgos-Bonvallet, Tommy Li, Zhu Li, Christian Eskelund, Umar Farooq
Journal: Blood
Blood (2023) 142 (Supplement 1): 1729.
https://doi.org/10.1182/blood-2023-180333
Published: 2023
Journal Articles

Epcoritamab SC + GemOx Leads to High Complete Metabolic Response Rates in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Ineligible for Autologous Stem Cell Transplant: Updated Results from Epcore NHL-2

Joshua Brody, Judit Mészáros Joergensen, David Belada, Regis T. Costello, Marek Trněný, Umberto Vitolo, David Lewis, Yasmin H. Karimi, Anna Maria Sureda Balari, Marc André, Björn E. Wahlin, Pieternella Lugtenburg, Faith Galderisi, Aqeel Abbas, Yaou Song, Malene Risum, Raul Cordoba
Journal: Blood
Blood (2023) 142 (Supplement 1): 3092.
https://doi.org/10.1182/blood-2023-180246
Published: 2023
Journal Articles

Epcoritamab SC Monotherapy Leads to Deep and Durable Responses in Patients with Relapsed or Refractory Follicular Lymphoma: First Data Disclosure from the Epcore NHL-1 Follicular Lymphoma Dose-Expansion Cohort

Kim Linton, Wojciech Jurczak, Pieternella Lugtenburg, Emmanuel Gyan, Anna Maria Sureda Balari, Jacob Haaber Christensen, Brian Hess, Hervé Tilly, Raul Cordoba, David Lewis, Craig Okada, Martin Hutchings, Michael Roost Clausen, Umberto Vitolo, Tara Cochrane, Sirpa Leppa, Martine E.D. Chamuleau, Rebekah Conlon, Elena Favaro, Diana Gernhardt, Isil Altintas, Yan Liu, Catherine Thieblemont
Journal: Blood
Blood (2023) 142 (Supplement 1): 1655.
https://doi.org/10.1182/blood-2023-179887
Published: 2023
Journal Articles

Improvements in Lymphoma Symptoms and Health-Related Quality of Life in Patients with Relapsed or Refractory Large B-Cell Lymphoma Treated with Subcutaneous Epcoritamab (EPCORE NHL-1)

Tycel Phillips, Pieternella Lugtenburg, Anupama Kalsekar, Alex Mutebi, Anthony Wang, Julie Blaedel, Katherine Kosa, Susan Martin, Mariana Sacchi, Catherine Thieblemont
Journal: Blood
Blood (2022) 140 (Supplement 1): 8022–8023.
https://doi.org/10.1182/blood-2022-159544
Published: 2022
Journal Articles

Epcoritamab Monotherapy Provides Deep and Durable Responses Including Minimal Residual Disease (MRD) Negativity: Novel Subgroup Analyses in Patients with Relapsed/Refractory (R/R) Large B-Cell Lymphoma (LBCL)

Tycel Phillips, Catherine Thieblemont, Herve Ghesquieres, Chan Y. Cheah, Michael Roost Clausen, David Cunningham, Young Rok Do, Tatyana A. Feldman, Robin Gasiorowski, Wojciech Jurczak, Tae Min Kim, David John Lewis, Marjolein van der Poel, Michelle Limei Poon, Nurgul Kilavuz, Mariana Cota Stirner, David Soong, Christopher Chiu, Menghui Chen, Mariana Sacchi, Brian Elliot, Martin Hutchings, Pieternella Lugtenburg
Journal: Blood
Blood (2022) 140 (Supplement 1): 9443–9445.
https://doi.org/10.1182/blood-2022-158245
Published: 2022
Journal Articles

Subcutaneous Epcoritamab with Rituximab + Lenalidomide in Patients with Relapsed or Refractory Follicular Lymphoma:Phase 1/2 Trial Update

Lorenzo Falchi, Pau Abrisqueta, Marcel Nijland, Sirpa Leppä, Martin Hutchings, Harald Holte, Reid W Merryman, Pieternella Lugtenburg, Sven de Vos, Chan Y. Cheah, Jacob Haaber Christensen, Luca Arcaini, Kristina Drott, Mats Hellström, Lori A. Leslie, Umberto Vitolo, Ali Rana, Aqeel Abbas, Liwei Wang, Minh Dinh, David Belada
Journal: Blood
Blood (2022) 140 (Supplement 1): 1464–1466.
https://doi.org/10.1182/blood-2022-158203
Published: 2022
Journal Articles

External Validation Shows That Baseline PET Radiomics Outperform the IPI Risk Score for Prediction of Outcome in DLBCL

Jakoba J Eertink, Gerben JC Zwezerijnen, Martijn W Heymans, Simone Pieplenbosch, Sanne E Wiegers, Ulrich Dührsen, Andreas Hüttmann, Lars Kurch, Christine Hanoun, Pieternella Lugtenburg, Sally F Barrington, George Mikhaeel, Luca Ceriani, Emanuele Zucca, Sandor Czibor, Tamás Györke, Martine E.D. Chamuleau, Otto S Hoekstra, Henrica C.W de Vet, Ronald Boellaard, Josée M. Zijlstra
Journal: Blood
Blood (2022) 140 (Supplement 1): 777–778.
https://doi.org/10.1182/blood-2022-163454
Published: 2022
Journal Articles

Therapies and Outcomes for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Contemporary, Nationwide, Population-Based Study in the Netherlands

Elise R.A. Pennings, Müjde Durmaz, Otto Visser, Eduardus F.M. Posthuma, Djamila E. Issa, Martine E.D. Chamuleau, Pieternella Lugtenburg, Marie José Kersten, Avinash G. Dinmohamed
Journal: Blood
Blood (2022) 140 (Supplement 1): 9564–9566.
https://doi.org/10.1182/blood-2022-159376
Published: 2022
Journal Articles

Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma

Jakoba J Eertink, Gerben J.C Zwezerijnen, Sanne E Wiegers, Martine E.D Chamuleau, Pieternella Lugtenburg, Daphne De Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Andreas Hüttmann, Christine Schmitz, Julia Richter, Wolfram Klapper, Otto S Hoekstra, Henrica C.W de Vet, Ronald Boellaard, Josée M Zijlstra
Journal: Blood
Blood (2021) 138 (Supplement 1): 451.
https://doi.org/10.1182/blood-2021-145855
Published: 2021
Journal Articles

The Optimal Timing of Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: An Individual Patient Data Meta-Analysis By the Petra Consortium

Jakoba J Eertink, MSc, Coreline N Burggraaff, MD, Martijn W Heymans, PhD, Sally F Barrington, Prof, MD PhD, George Mikhaeel, Prof, MD PhD, Ulrich Dührsen, Prof, MD PhD, Andreas Hüttmann, MD, Luca Ceriani, MD, Emanuele Zucca, MD, Robert Carr, MD, Tamás Györke, MD PhD, Stefano Fanti, Prof, MD PhD, Howard R Higley, PhD, Michael V Knopp, MD PhD, Heiko Schöder, MD, Annika Loft, MD PhD, Martin Hutchings, MD PhD, Lale Kostakoglu, Prof, MD PhD, Pieternella Lugtenburg, MD PhD, Sanne E Wiegers, MSc, Simone Pieplenbosch, MSc, Ronald Boellaard, MSc, PhD, Otto S Hoekstra, MD PhD, Josée M Zijlstra, MD PhD, Henrica C.W. de Vet, Prof, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 487.
https://doi.org/10.1182/blood-2019-122298
Published: 2019
Journal Articles

High Frequencies of Mutated EZH2 and IRF8 and Other Epigenetic Genes in Primary Bone Lymphomas Are Indicative of GCB-Phenotype

Ruben A.L. De Groen, Ronald Van Eijk, Tom van Wezel, Richard Raghoo, Anne-Roos Schrader, MD, Patty M. Jansen, MD PhD, Inge briaire-De Bruijn, Karin Kleiverda, Tom Vlasveld, Valeska Terpstra, Henriette Levenga, Aline Nicolae, Ward Posthuma, MD PhD, Isabelle Focke-Snieders, Lizan Hardi, Wietske den Hartog, Anke Van Den Berg, PhD, Arjan Diepstra, Pieternella Lugtenburg, MD PhD, Marie José Kersten, MD PhD, Steven T Pals, MD PhD, Hendrik Veelken, MD PhD, Judith Bovée, Arjen Cleven, MD PhD MSc, Joost Vermaat, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1484.
https://doi.org/10.1182/blood-2019-129832
Published: 2019
Journal Articles

First-in-Human, Phase 1/2 Trial to Assess the Safety and Clinical Activity of Subcutaneous GEN3013 (DuoBody ® -CD3×CD20) in B-Cell Non-Hodgkin Lymphomas

Pieternella Lugtenburg, MD PhD, Rogier Mous, MD PhD, Michael Roost Clausen, Martine E.D. Chamuleau, Peter Johnson, MDFRCP, Kim Linton, PhD, Simon Rule, Roberto S Oliveri, MD PhD, Dena DeMarco, Ida H Hiemstra, PhD, Guang Chen, Ada Azaryan, Manish Gupta, Tahamtan Ahmadi, Martin Hutchings, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 758.
https://doi.org/10.1182/blood-2019-121460
Published: 2019
Journal Articles

PET-Based Response after 2 Cycles of Brentuximab Vedotin in Combination with AVD for First-Line Treatment of Unfavorable Early-Stage Hodgkin Lymphoma: First Analysis of the Primary Endpoint of Breach, a Randomized Phase II Trial of Lysa-FIL-EORTC Intergroup

Luc-Matthieu Fornecker, Julien Lazarovici, MD, Igor Aurer, PhD, Rene-Olivier Casasnovas, MD, Anne-Claire Gac, Christophe Bonnet, MD PhD, Krimo Bouabdallah, MD, Aurore Perrot, MD, Lena Specht, Mohamed Touati, Jean Claude Eisenmann, Cecile Borel, MD, Aspasia Stamatoullas, MD, Emmanuelle Nicolas-Virelizier, MD, Laurent Pascal, Pieternella Lugtenburg, Monica Bellei, MSc, PhD, Alexandra traverse-Glehen, MD PhD, Christiane Copie, MDPhD, Martin Hutchings, MD PhD, Annibale Versari, Michel Meignan, Massimo Federico, Marc Andre, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 736.
https://doi.org/10.1182/blood.V130.Suppl_1.736.736
Published: 2017